Novel Biomarkers for Thrombosis Risk Prediction in Non–Small-Cell Lung Cancer: Insights from Recent Evidence
Venous thromboembolism (VTE) represents a significant cause of morbidity and mortality in patients with cancer,...
Most Read
The Evolving Landscape of Cerebral Venous Sinus Thrombosis: Emerging Risk Factors and Treatments
Cerebral venous sinus thrombosis (CVST) is a rare yet serious condition, representing an uncommon manifestation of...
SAVE THE DATE – The 13th International Conference on Thrombosis and Hemostasis Issues in Cancer
The 13th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC) will next be...
Disseminated Intravascular coagulation in solid and hematological cancers
Introduction There is a clear relationship between malignancy and deranged coagulation. Patients with cancer are at...
Risk prediction for cancer‐associated thrombosis: A talk with Prof. Pabinger
Professor Pabinger is a hematologist at the University of Vienna, where she studies cancer and thrombosis. During the...
The 10th International Conference on Thrombosis and Hemostasis Issues in Cancer
The 10th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC) will next be held on 17–19...
Thrombocytopenia and management of anticoagulation in the patient with thrombosis and cancer
Cancer-associated thrombosis (CAT) presents a unique and multifaceted challenge in clinical practice, particularly in...
CAT management in older cancer patients
During the ICTHIC webinar, “Challenges in the management of fragile CAT patients (older patient population &...
The XXVII Congress of the International Society on Thrombosis and Haemostasis
Taking place in Melbourne, Australia, July 6-10, 2019, the ISTH 2019 celebrates its 27th Edition and features the...